Therefore, improved handling procedures were developed which indeed resulted in a better graft performancel'. 12,14,15,17, However, other factors which are inherent to the transplantation procedure leading to damage of the vein graft are ischaemia due to the interruption of the vasa vasorum and overstretching of the vein graft wall due to the arterial blood pressure13'18-20. Overstretching is caused because the vein graft has a poorly developed medium with few smooth muscle cell layers which is not adapted to the relatively high arterial pressures. Overstretching may lead to a loss of the integrity of the graft wall and ultimately to graft failure. Therefore, it is expected that if overstretching is prevented, the graft performance will be improved. This was confirmed by Barra et al. 'l and Karayannacos et al." , who have shown that a constrictive Dacron mesh applied around the vein graft reduces the degree of deterioration of the vein wall. The long-term fate of these composite vein grafts, however, might be less successful. These prostheses are non-compliant, which might induce intimal hyperplasia formation at the anastomotic sidesz3. Furthermore, the prostheses are non-resorbable, which might cause perigraft fibrosisz4 and ultimately constriction of the grafts.
The aim of this study was to evaluate whether damage due to overstretching can be prevented and a gradual adaptation of the vein graft to the arterial blood pressures can be induced by applying a microporous, elastomeric, degradable prosthesis around the vein graft. Therefore, autologous vein grafts (length l.Ocm) with and without supporting prostheses (composite vein graft and control vein graft, respectively) were interposed into both carotid arteries of rabbits and evaluated up to 6 wk after implantation. To study the effects of degradation of the prostheses on the arterialization process, different compositions of prostheses with different degradation rates were tested. A discussion will be given on the suitability of several types of polymer systems for this application.
MATERIALS AND METHODS

Materials
Polyetherurethane
Estane " 5714fl (PEU; Goodrich, Leidschendam,
The Netherlands) was purified by precipitation of a 10 wt% solution in N,N-dimethylformamide (DMF) into water. Poly-c-caprolactone (PCl; Interox Chemical Ltd, ~a~ington, UK] and poly(~-lactide) (PLLA; TNO, Delft, The Netherlands) were purified by precipitation of 10 wt% solutions in chloroform (CHCIS) into methanol. A copolymer of s-caprolactone and 3,6-dimethyl-1,4-morpholine-2,5-dione (monomer ratio 95.5:4.5; Cop 4.5) was synthesized as described by in't Veld et d2'. The intrinsic viscosities of solutions of PLLA in CHCl, and of PC1 and Cop 4.5 in tetrahydrofuran (THF), as determined with an Ubbelohde viscometer at 25"C, were 2.60, 0.63 and 0.82 dl/g, respectively.
Fractions of sodium citrate (Janssen, Beerse, Belgium) differing in particle size were obtained as follows. A saturated solution of sodium citrate in a 1:2 (v/v) mixture of methanol and water was cooled from 70 to 
Fabrication and characterization of the prostheses
Prostheses composed of PEU-PLLA (9O:lO wt"h) and PEU-PC1 (9O:lO wt%) were prepared by means of a repeated immersion precipitation/salt casting technique 26*27. A glass rod (diameter 2.5mm) was dipped into a suspension of a polymer solution and sodium citrate particles at ambient temperature. Subsequently, the glass rod on which a layer of the suspension was deposited was placed for 5 s into ethanol-water (90~10 wt%) and therea~er for 10 min into ethanol-water (5050 wt%), also at ambient temperature to induce polymer precipitation.
Thereafter the precipitated polymer was exposed to air until nearly dry and the next layer was deposited on top of the first one by means of the same procedure. This procedure was continued until five layers were deposited. Then the prostheses were thoroughly rinsed in water and ethanol to dissolve the salt particles and to extract the solvent residues, and subsequently stored in ethanol. The composition of the suspension used for the preparation of the first four layers was PEU-PLLA-DMF-THF-~HCl~-sodium citrate (particle size <38pm) (4.5:0.5:44.0:12.0:28.4:10.6 wt%) or PEU-PCl-DMF-THF-sodium citrate (particle size ~38 pm) (5.4:0.6:69.0:12.1:12.9 wt%) and for the last layer PEW-PLLA-DMF-THF-CHCI,-sodium citrate (particle size 68-106 pm) (3.4:0.3:38.0:4.8:23.0:30.5 wt%) or PEU-Pal-DMF-THF-sodium citrate (particle size 68-106pm) (4.5:0.5:49.1:8.7:37.2 wt%). Prostheses composed of PC1 were prepared by means of a two-step thermally induced phase separation/salt casting techniquez7.
These prostheses were also prepared by depositing a number of layers onto a glass rod (diameter 2.5 mm) by means of dip coating. In this case, polymer precipitation was induced by cooling a suspension of a polymer solution and sodium citrate particles. After the glass rod was dipped into the suspension at 6O"C, the glass rod containing a layer of the suspension was cooled to ambient temperature for 15 min. Subsequently, the prostheses were placed into water~thanol (25:75 wt%) for 15 min, also at ambient temperature, to partially extract the solvent. The prostheses were then exposed to air until nearly dry and the second layer was deposited by means of the same procedure. After two layers had been deposited, the prostheses were treated like the PEU-based prostheses. The composition of the suspension used for the preparation of the first layer was PCl-DMS~sodium citrate (particle size <38,itm) (10:57.3:32.7 wt%) and The porous structures of the prostheses were evaluated by means of scanning electron microscopy (SEM). Therefore, the prostheses were coated with a layer of gold with a Balzer sputter unit and examined with a Jeol JSM 35 scanning electron microscope operating at 15 kV.
The mechanical properties of the prostheses were evaluated by means of stress-strain measurements. The prostheses were wetted with distilled water and subsequently fixed between the clamps of an Instron tensile tester (Floor model TT-CM).
The prostheses (n = 3), with a length of 1 cm, were drawn in the longitudinal direction with a speed of 0.5 cm/min at 25 'C until breakage.
Implantation
Both left and right carotid arteries of male Chinchilla rabbits weighing 3.0-3.5 kg were used to evaluate composite vein grafts consisting of autologous veins surrounded by prostheses. One centimetre segments of the jugular veins were harvested and interposed into the carotid arteries with end to end anastomoses.
The vein grafts were implanted by means of microsurgical techniques, as described before"'. The vein grafts with supporting prostheses were implanted as shown schematically in Figure Z . The prostheses had a length of 1.5 cm and overlapped both anastomoses.
Both types of graft were anastomosed to the carotid arteries with interrupted sutures (Ethilon 9-0, BV-4 needle, Ethicon). Vein grafts matching the diameter of the carotid artery (2.5 mm) and oversized vein grafts (3.5 mm) were used for the Control n 6 n 6 n-a PEU-PCI (9:l) n :~ 6 n -6 n=7 PEU-PLLA (9:l) n-6 n-6 n-a
n: 6 n-6 n=a control and composite grafts, respectively. The grafts were harvested at different time intervals (see ?'nble Z) and prepared for SEM and light microscopy (LM) by means of standard procedures""."".
The wall thickness and the inner diameter of the explanted vein grafts and the carotid artery were determined as described before"". The data were mutually compared by means of the Mann-Whitney test. The data were considered to be significantly different when P < 0.05. pores were only formed by the entrapment of sodium citrate particles in the polymer matrix during precipitation and the subsequent extraction of the sodium citrate particlesz7. Therefore, these prostheses had a different pore morphology.
RESULTS
Characteristics of the prostheses
The prostheses showed a leafy structure with a relatively poor interconnectivity of the pores. All four types of prosthesis showed elastomeric behaviour at 25°C (see Figure 3) . However, the elastomeric properties of the PC1 and Cop 4.5 prostheses as expressed in the values for the strain at breakage were not as good as those of the PEU-based prostheses. Furthermore, the PC1 and Cop 4.5 prostheses had higher initial moduli than the PEU-based prostheses. These differences can be ascribed to differences in specific characteristics of the materials from which the prostheses were made, as well as to differences in weight per length of the prostheses.
In viva experiments
Control grafts
One week implants: the inner surfaces of the control vein grafts were denuded from endothelium for 50%. The graft wall had an edematous appearance and was infiltrated by many polymorphonuclear leucocytes. Furthermore, the smooth muscle layers were completely disrupted and showed only fragments of the elastic laminae (see Figure 4a) .
Three week implants: the endothelium was fully recovered and the edema had disappeared. Irregular proliferated cells, most likely mature fibroblastszg, had partially replaced the areas of inflammation, while the elastic laminae could no longer be observed.
Six week implants: irregular proliferated mature fibroblasts had completely replaced the areas of inflammation (see Figure 4b) . Figure  4~ ). The inner diameter of all vein grafts was equal to that of the adjacent artery (see Table 3 ). The wall thickness of the vein grafts was the same in all cases, but smaller than that of the adjacent artery (see grafts the inner diameter was equal to that of the adjacent artery (see Table 3 ). In all cases the wall of the vein grafts was increased in thickness as compared to the 1 wk implants but was still thinner than that of the adjacent artery (see Table 4 ). The wall thickness was increased by the development of regular layers of circularly oriented cells, most likely young and immature fibroblasts, beneath the well preserved smooth muscle cell layers'". The Cop 4.5 prostheses were degraded excessively: only fragments of the prosthetic material were left. The PEU-PLLA prostheses were also fragmented, although less excessively than the Cop 4.5 prostheses.
Composite grafts
The PEU-PC1 and PC1 prostheses did not show signs of fragmentation. The Cop 4.5 prostheses showed infiltration of many capillaries and multinuclear giant cells over the whole thickness of the prosthetic wall. The same picture was seen in both PEU-based prostheses, whereas only very limited perigraft tissue ingrowth was observed in the PC1 prostheses.
Six week implants: the vein grafts supported by the Cop 4.5 prostheses did not show a further dilation. In all other cases the inner diameter of the vein grafts still equalled that of the adjacent artery (see Table 3 ).
The wall of the dilated vein grafts supported by the Cop 4.5 prostheses was further thickened as compared to the 3 wk implants but was still thinner than that of the adjacent artery. The wall thickness of the vein grafts supported by the PEU-PLLA prostheses had reached that of the adjacent artery, whereas those of the vein grafts supported by the PEU-PC1 prostheses (see Figure 4d) were still thinner than that of the adjacent artery (see Table 4 ). Wrinkling or folding of the vein grafts was never observed during the 6 wk of implantation.
DISCUSSION
Our results clearly demonstrate that the arterialization of autologous vein grafts used for the reconstruction of small diameter arteries is improved when a microporous, elastomeric and degradable prosthesis supports the vein graft. The results particularly demonstrate that the vein grafts adapt gradually and regularly to the arterial conditions when the degradation of the prostheses is in step with the biological regeneration process. After implantation, the control grafts showed severe destructive changes including de-endothelialization, complete disruption of the smooth muscle layers with edema, disintegration of the elastic laminae and an inflammatory reaction. In contrast, the prostheses used to support the vein grafts reduced these destructive changes and prevented an inflammatory reaction in the wall. The severe destructive changes observed in the control vein grafts can therefore only be ascribed to the distension by the arterial pressures and pulsatile blood flow. We used oversized vein grafts in the prostheses to ensure that overstretching could not occur. Therefore, the minor damage still observed might be ascribed to the handling procedures during transplantation and ischaemia. In time, the wall of the vein grafts gradually increased in thickness by the formation of regular circularly oriented cellular layers beneath the original longitudinally oriented smooth muscle cell layers, indicating a regular adaptation of the vein wall to the arterial blood pressures and pulsatile blood flow, i.e. arterialization.
These circularly oriented cellular layers consisted of young and immature fibroblastszg, which have the potential to transform into smooth muscle cells.
Because the fibroblast layers formed highly organized structures, this transformation is likely to occur or had already been started. However, long-term in viva experiments are required to investigate whether under these conditions the fibroblasts are indeed transformed into smooth muscle cells and a medium resembling that of an artery of normal architecture and function develops. In contrast, the control vein grafts showed no regularly and circularly oriented cellular layers at 6wk and because of the mature aspect of fibroblasts, a transformation of the fibroblasts into smooth muscle cells is not likely. Preferably, a foreign material should remain in the body only as long as it is required.
In our animal model, the PEU-PLLA prostheses induced the best balance of rapid degradation and optimal arterialization of the vein grafts. However, the degradation rate in a clinical situation might be different since the arterialization rate is likelv to be species dependent"", "' and is furthermore determined by the original thickness of the vein graft wall. Therefore, a series of prostheses differing in degradation rate should be available.
In the present study we used two different PEIJ-based prostheses, the PEU-PLLA and PEIJ-PC1 prostheses, which lost their supporting function at different rates. In a previous study, in which these prostheses were used as vascular substitutes, it was shown that the prostheses fragment in viva by alternating stresses induced by arterial pulsationsZf'. Bv changing the composition of these prostheses, a series of prostheses with a broad range of fragmentation rates can he obtained"',"". Therefore, this series of prostheses seems ideal as supporting prostheses for vein grafts. However, care must he exercised to apply fragmentable prostheses based on polyurethanes in humans because it is not known how long it takes until the polymer fragments are degraded completely and whether degradation products accumulate in the body. Moreover, when polyurethanes in which the hard segments are based on aromatic diisocyanatos are used, highly toxic aromatic: diamines may he formed during degradation""m44.
Alternatives for blend prostheses are prostheses composed of biodegradable elastomeric copolymers which are built up from non-toxic naturally occurring metabolites and of which the degradation rate can he varied by changing the monomer ratio. The Cop 4.5 and PC1 prostheses used in the present study belong to such a series of prostheses.
It was found that the PC1 prostheses degraded slowly. Qualitative inspections of the implant 6wk after implantation did not show any loss of integrity of the prostheses and even 6 months after implantation the prostheses still seemed relatively unaffected (data not shown).' In contrast, the Cop 4.5 prostheses degraded very rapidly. After 3 wk of implantation only fragments of the material were left and after 6 wk of implantation the material had completely disappeared. These findings indicate that a series of prostheses with a very broad range of degradation rates can be prepared by varying the c-caprolactone-morpholinedione ratio between %.5:,4.5 and 100:O. Therefore, we recommend prostheses made of these copolymers to support the vein grafts. Grune & Stratton, 1982: 11-26. 
